| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |